NASDAQ:EYPT

Eyepoint Pharmaceuticals Stock News

etoro logo Buy EYPT
*Your capital is at risk
$12.34
-0.190 (-1.52%)
At Close: Jun 03, 2026
Despite valuations looking expensive, the markets are in a good place as of this morning, despite the cases for coronavirus spiking over the weekend. Some may say the market is getting ahead of itself
EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT): EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company...
In a report released today, Yi Chen from H.C. Wainwright initiated coverage with a Buy rating on Applied DNA Sciences
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA
In a report released yesterday, Andrew D’silva from B.Riley FBR maintained a Buy rating on Intricon (IIN – Research Report),
If you’re looking to hedge against a coming pullback in the markets, we've used our deep learning algorithms and AI to identify the Top Shorts today.
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Celcuity (CELC – Research Report),
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fate Therapeutics (FATE – Research
Shares of Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) gapped up before the market opened on Thursday . The stock had previously closed at $0.88, but opened at $0.88. Eyepoint Pharmaceuticals shares las
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on HTG Molecular Diagnostics (HTGM –
EyePoint Pharmaceuticals (EYPT) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE